Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus

BACKGROUND: Diabetic nephropathy is a leading cause of end-stage renal disease. The diagnostic markers of nephropathy, including the presence of albuminuria and/or a reduced estimated glomerular filtration rate, are not clinically ideal, and most of them are raised after a significant reduction in r...

Descripción completa

Detalles Bibliográficos
Autores principales: Dejenie, Tadesse Asmamaw, Abebe, Endeshaw Chekol, Mengstie, Misganaw Asmamaw, Seid, Mohammed Abdu, Gebeyehu, Natnael Atnafu, Adella, Getachew Asmare, Kassie, Gizchew Ambaw, Gebrekidan, Amanuel Yosef, Gesese, Molalegn Mesele, Tegegne, Kirubel Dagnaw, Anley, Denekew Tenaw, Feleke, Sefineh Fenta, Zemene, Melkamu Aderajew, Dessie, Anteneh Mengist, Moges, Natnael, Kebede, Yenealem Solomon, Bantie, Berihun, Adugna, Dagnew Getnet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112538/
https://www.ncbi.nlm.nih.gov/pubmed/37082121
http://dx.doi.org/10.3389/fendo.2023.1124367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112538/
https://www.ncbi.nlm.nih.gov/pubmed/37082121
http://dx.doi.org/10.3389/fendo.2023.1124367

Ejemplares similares